SKI Market

A+| A| A-|

Indian Indices

Sensex

76,888.36 -775.64
( -1.00%)

Global Indices

Nasdaq

49,330.80 -180.24
(-0.36%)

Dow Jones

7,129.46 -29.44
(-0.41%)

Hang Seng

59,249.10 -336.76
(-0.57%)

Nikkei 225

10,468.22 -8.24
(-0.08%)

Forex

USD-INR

93.75 0.31
(0.34%)

EUR-INR

109.98 0.10
(0.09%)

GBP-INR

126.66 0.42
(0.33%)

JPY-INR

0.59 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

38.31

756.53

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

housing development & infrastructure ltd

Share India Securities consolidated net profit rises 8.04% in the December 2025 quarter

Jan 28,2026

Net profit of Share India Securities rose 8.04% to Rs 88.55 crore in the quarter ended December 2025 as against Rs 81.96 crore during the previous quarter ended December 2024. Sales rose 8.70% to Rs 371.97 crore in the quarter ended December 2025 as against Rs 342.20 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	371.97	342.20	9
OPM %	41.96	38.35	-
PBDT	126.82	116.27	9
PBT	122.35	111.93	9
NP	88.55	81.96	8

76,888.36 -775.64 ( -1.00%)

49,330.80 -180.24 (-0.36%)

7,129.46 -29.44 (-0.41%)

59,249.10 -336.76 (-0.57%)

10,468.22 -8.24 (-0.08%)

93.75 0.31 (0.34%)

109.98 0.10 (0.09%)

126.66 0.42 (0.33%)

0.59 0.00 (0.23%)